Artal Group S.A. — Q1 2026 13F-HR

← Artal Group S.A.

Q1 2026 · 13F-HR

Artal Group S.A.holdings as filed

Filed 2026-05-14 · accession 0001053906-26-000006

$1.01B

Reported value

Positions

2026-03-31

Period end

View analyzed profile →PRO

The Brief · Artal Group S.A. · Q1 2026

AI · grounded in 13F

Artal Group S.A. increased its position in Lexicon Pharmaceuticals Inc LXRX by 13.62%. The fund added one new position to its portfolio. Total assets under management stood at $1.01B with two total positions.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
148929102	CAVA	Cava Group Inc	$769.2M	76.1%	9,507,990	Common	SOLE
528872302	LXRX	Lexicon Pharmaceuticals Inc	$241.4M	23.9%	154,734,327	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.